| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accuracy and efficacy of pre-dengue vaccination screening for previous dengue infection with five commercially available immunoassays: a retrospective analysis of phase 3 efficacy trials
|
DiazGranados, Carlos A
|
|
|
21 |
4 |
p. 529-536
|
artikel
|
| 2 |
A doctor's odyssey
|
Bloom, Barry
|
|
|
21 |
4 |
p. 470
|
artikel
|
| 3 |
A glimmer of hope beyond the spring for Europe
|
The Lancet Infectious Diseases,
|
|
|
21 |
4 |
p. 439
|
artikel
|
| 4 |
A need for open public data standards and sharing in light of COVID-19
|
Gardner, Lauren
|
|
|
21 |
4 |
p. e80
|
artikel
|
| 5 |
Anti-vaxxers! Let's move on!
|
Balakrishnan, Vijay Shankar
|
|
|
21 |
4 |
p. 471
|
artikel
|
| 6 |
A public health ethic should inform policies on COVID-19 immunity passports
|
Baylis, Françoise
|
|
|
21 |
4 |
p. 456
|
artikel
|
| 7 |
A public health ethic should inform policies on COVID-19 immunity passports – Authors' reply
|
Brown, Rebecca C H
|
|
|
21 |
4 |
p. 456-457
|
artikel
|
| 8 |
Association of tiered restrictions and a second lockdown with COVID-19 deaths and hospital admissions in England: a modelling study
|
Davies, Nicholas G
|
|
|
21 |
4 |
p. 482-492
|
artikel
|
| 9 |
Asymptomatic SARS-CoV-2 infection in Belgian long-term care facilities
|
Hoxha, Ana
|
|
|
21 |
4 |
p. e67
|
artikel
|
| 10 |
Behind Cuba's successful pandemic response
|
Burki, Talha
|
|
|
21 |
4 |
p. 465-466
|
artikel
|
| 11 |
Bell's palsy and SARS-CoV-2 vaccines
|
Ozonoff, Al
|
|
|
21 |
4 |
p. 450-452
|
artikel
|
| 12 |
Bin Cao—a leader in respiratory medicine
|
Samarasekera, Udani
|
|
|
21 |
4 |
p. 469
|
artikel
|
| 13 |
Carriage rates of multidrug-resistant organisms among prospective stool donors
|
Zaman, Amanda
|
|
|
21 |
4 |
p. 454-455
|
artikel
|
| 14 |
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
|
Standl, Fabian
|
|
|
21 |
4 |
p. e77
|
artikel
|
| 15 |
Correction to Lancet Infect Dis 2020; 20: e149–158
|
|
|
|
21 |
4 |
p. e81
|
artikel
|
| 16 |
Correction to Lancet Infect Dis 2021; online Feb 3. https://doi.org/10.1016/S1473-3099(21)00043-8
|
|
|
|
21 |
4 |
p. e81
|
artikel
|
| 17 |
Correction to Lancet Infect Dis 2021; published online Feb 8. https://doi.org/10.1016/S1473-3099(21)00078-5
|
|
|
|
21 |
4 |
p. e81
|
artikel
|
| 18 |
Correction to Lancet Infect Dis 2020; published online Feb 16. https://doi.org/10.1016/S1473-3099(20)30784-2
|
|
|
|
21 |
4 |
p. e81
|
artikel
|
| 19 |
Correction to Lancet Infect Dis 2021; published online Jan 20. https://doi.org/10.1016/S1473-3099(20)30990-7
|
|
|
|
21 |
4 |
p. e81
|
artikel
|
| 20 |
Correction to Lancet Infect Dis 2021; published online Jan 21. https://doi.org/10.1016/S1473-3099(20)30942-7
|
|
|
|
21 |
4 |
p. e81
|
artikel
|
| 21 |
COVID-19 pandemic more than a century after the Spanish flu
|
Javelle, Emilie
|
|
|
21 |
4 |
p. e78
|
artikel
|
| 22 |
COVID-19 vaccination in Ukraine
|
Holt, Edward
|
|
|
21 |
4 |
p. 462
|
artikel
|
| 23 |
Cyber harassment of female scientists will not be the new norm
|
Samer, Caroline
|
|
|
21 |
4 |
p. 457-458
|
artikel
|
| 24 |
Dental procedure aerosols and COVID-19
|
Epstein, Joel B
|
|
|
21 |
4 |
p. e73
|
artikel
|
| 25 |
Desideratum: a developmentalist view of Zika virus infection
|
Einspieler, Christa
|
|
|
21 |
4 |
p. 444-445
|
artikel
|
| 26 |
Ebola and COVID-19 in DR Congo and Guinea
|
Adepoju, Paul
|
|
|
21 |
4 |
p. 461
|
artikel
|
| 27 |
Effect of pneumococcal conjugate vaccines on invasive pneumococcal disease
|
Camargos, Paulo
|
|
|
21 |
4 |
p. 453
|
artikel
|
| 28 |
Effect of pneumococcal conjugate vaccines on invasive pneumococcal disease – Authors' reply
|
de Cunto Brandileone, Maria Cristina
|
|
|
21 |
4 |
p. 453-454
|
artikel
|
| 29 |
Evolving ethics of COVID-19 challenge trials
|
Manheim, David
|
|
|
21 |
4 |
p. e79
|
artikel
|
| 30 |
Excess mortality from COVID-19 in an English sentinel network population
|
Joy, Mark
|
|
|
21 |
4 |
p. e74
|
artikel
|
| 31 |
Harmonisation preserves research resources
|
Vasconcelos, Malte Kohns
|
|
|
21 |
4 |
p. e71
|
artikel
|
| 32 |
Horizontal transmission of HTLV-1 causing uveitis
|
Kamoi, Koju
|
|
|
21 |
4 |
p. 578
|
artikel
|
| 33 |
Immunity to Ebola virus: the full picture is being revealed
|
Etard, Jean-François
|
|
|
21 |
4 |
p. 441-442
|
artikel
|
| 34 |
Immunogenicity and safety of simplified vaccination schedules for the CYD-TDV dengue vaccine in healthy individuals aged 9–50 years (CYD65): a randomised, controlled, phase 2, non-inferiority study
|
Coronel-MartÍnez, Diana Leticia
|
|
|
21 |
4 |
p. 517-528
|
artikel
|
| 35 |
In favour of a bespoke COVID-19 vaccines compensation scheme
|
Fairgrieve, Duncan
|
|
|
21 |
4 |
p. 448-450
|
artikel
|
| 36 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
|
21 |
4 |
p. 466
|
artikel
|
| 37 |
Keeping childhood immunisation rates stable during the COVID-19 pandemic
|
Jarchow-MacDonald, Anna A
|
|
|
21 |
4 |
p. 459-460
|
artikel
|
| 38 |
Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study
|
Thom, Ruth
|
|
|
21 |
4 |
p. 507-516
|
artikel
|
| 39 |
Lung fibrosis: an undervalued finding in COVID-19 pathological series
|
Grillo, Federica
|
|
|
21 |
4 |
p. e72
|
artikel
|
| 40 |
Multiple testing and the effect of NPIs on the spread of SARS-CoV-2
|
Rothe, Christoph
|
|
|
21 |
4 |
p. 458
|
artikel
|
| 41 |
Optimising dengue pre-vaccination screening
|
Wilder-Smith, Annelies
|
|
|
21 |
4 |
p. 442-444
|
artikel
|
| 42 |
Pandemic psyche
|
Balakrishnan, Vijay Shankar
|
|
|
21 |
4 |
p. 472
|
artikel
|
| 43 |
Potential factors linked to high COVID-19 death rates in British minority ethnic groups
|
Cook, Marion
|
|
|
21 |
4 |
p. e68
|
artikel
|
| 44 |
Raina MacIntyre—expert in infectious disease outbreaks
|
Kirby, Tony
|
|
|
21 |
4 |
p. 468
|
artikel
|
| 45 |
Research in brief
|
Devi, Sharmila
|
|
|
21 |
4 |
p. 467
|
artikel
|
| 46 |
Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study
|
Cohen, Dani
|
|
|
21 |
4 |
p. 546-558
|
artikel
|
| 47 |
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial
|
Pollard, Andrew J
|
|
|
21 |
4 |
p. 493-506
|
artikel
|
| 48 |
Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial
|
Bandyopadhyay, Ananda S
|
|
|
21 |
4 |
p. 559-568
|
artikel
|
| 49 |
SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study
|
Poustchi, Hossein
|
|
|
21 |
4 |
p. 473-481
|
artikel
|
| 50 |
SCORE report urges for better health information systems
|
Bagcchi, Sanjeet
|
|
|
21 |
4 |
p. 464
|
artikel
|
| 51 |
Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland
|
Perez-Saez, Javier
|
|
|
21 |
4 |
p. e69-e70
|
artikel
|
| 52 |
SeroTracker: a global SARS-CoV-2 seroprevalence dashboard
|
Arora, Rahul K
|
|
|
21 |
4 |
p. e75-e76
|
artikel
|
| 53 |
Spatial and molecular mapping of Pfkelch13 gene polymorphism in Africa in the era of emerging Plasmodium falciparum resistance to artemisinin: a systematic review
|
Kayiba, Nadine K
|
|
|
21 |
4 |
p. e82-e92
|
artikel
|
| 54 |
Summary of evidence to reduce the two-dose infant priming schedule to a single dose of the 13-valent pneumococcal conjugate vaccine in the national immunisation programme in the UK
|
Ladhani, Shamez N
|
|
|
21 |
4 |
p. e93-e102
|
artikel
|
| 55 |
The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials
|
Singh, Jerome Amir
|
|
|
21 |
4 |
p. e103-e109
|
artikel
|
| 56 |
The search for an efficacious shigella vaccine
|
Wierzba, Thomas F
|
|
|
21 |
4 |
p. 446-447
|
artikel
|
| 57 |
UK guidelines and testing for invasive meningococcal disease
|
Clark, Stephen A
|
|
|
21 |
4 |
p. 455-456
|
artikel
|
| 58 |
Vaccine innovation spurred by the long wait for an Ebola virus vaccine
|
Fausther-Bovendo, Hugues
|
|
|
21 |
4 |
p. 440-441
|
artikel
|
| 59 |
Vacuna-gate escalates in Peru
|
Kenyon, Georgina
|
|
|
21 |
4 |
p. 463
|
artikel
|
| 60 |
Validating clinical practice guidelines for the management of children with non-blanching rashes in the UK (PiC): a prospective, multicentre cohort study
|
Waterfield, Thomas
|
|
|
21 |
4 |
p. 569-577
|
artikel
|
| 61 |
Vanishing evidence of the non-blanching rash?
|
Borensztajn, Dorine M
|
|
|
21 |
4 |
p. 447-448
|
artikel
|
| 62 |
Vertical transmission of Zika virus and its outcomes: a Bayesian synthesis of prospective studies
|
Ades, A E
|
|
|
21 |
4 |
p. 537-545
|
artikel
|
| 63 |
Why development of outbreak analytics tools should be valued, supported, and funded
|
Jombart, Thibaut
|
|
|
21 |
4 |
p. 458-459
|
artikel
|
Tijdschrift beschrijving